N/A
Completed N=326
The Learning Curve of NBI With Magnification in the Diagnosis of Colorectal Lesions
Colorectal Lesion
Source: ClinicalTrials.gov NCT01431703 ↗
Enrolled (actual)
326
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Accuracy, Sensitivity, and Specificity for Differentiating Neoplastic and Non-neoplastic Lesions — 94.3; 98.0; 92.0 percentage of lesions
Summary
It exists a learning curve in using NBI with magnification to differentiating colorectal lesions.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Accuracy, Sensitivity, and Specificity for Differentiating Neoplastic and Non-neoplastic Lesions |
94.3; 98.0; 92.0 | — |
Eligibility Criteria
Inclusion Criteria
- Ages 16 to 85
- Any patient undergoing NBI with magnification colonoscopy exam and found with colorectal lesions
Exclusion Criteria
- Unwilling to consent
- Had surgery of colorectal tumors
- Using NSAIDS
- Diagnosed or suspected IBD
- Familial adenomatous polyposis(FAP) or hereditary non-polyposis colorectal(HNPCC) or other hereditary disease
Data sourced from ClinicalTrials.gov (NCT01431703). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.